Chugai Pharmaceutical Co. Ltd.'s Fiscal Year is From January To December - All Figures are in JPY, Billions.
The item "Net-Income-Applicable-To-Common-Shares" stands at 395.48 Billion Japanese Yens for the trailing twelve months (TTM) period ending 06/30/2025.
Chugai Pharmaceutical Co. Ltd.'s second quarter result of 97.16 Billion JPY for the item "Net Income Applicable To Common Shares" represents a decrease of -0.08 percent compared to it's first quarter result.
Also, Chugai Pharmaceutical Co. Ltd.'s second quarter result of 97.16 Billion JPY for the item "Net Income Applicable To Common Shares" represents a decrease of -13.15 percent compared to it's second quarter result of last year.
Looking again at the trailing twelve months series (TTM), Chugai Pharmaceutical Co. Ltd.'s second quarter result of 395.48 Billion JPY for the item "Net Income Applicable To Common Shares" represents a decrease of -3.58 percent compared to it's first quarter result.
Regarding the One-Year-Change of the series, the current value constitutes an increase of 11.39 percent compared to the value the year prior.
The 1 year change in percent is 11.39.
The 3 year change in percent is 1.66.
The 5 year change in percent is 107.50.
The 10 year change in percent is 657.33.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Net Income Applicable To Common Shares | 905,699,262,464.00 |
![]() | Johnson & Johnson - Net Income Applicable To Common Shares | 486,508,953,600.00 |
![]() | AbbVie Inc - Net Income Applicable To Common Shares | 399,570,305,024.00 |
![]() | Roche Holding AG - Net Income Applicable To Common Shares | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Net Income Applicable To Common Shares | 280,205,508,085.11 |